24.10.2022 | Tracker

Respiratory tracker: HCPs discuss inhaler technique during #askaboutasthma and react to patients’ response to cost of living crisis

By Mark Sullivan

In the 30 days between 21 September and 20 October, the activity of UK HCPs discussing respiratory disease online was tracked by CREATION Pinpoint®, with 3,682 mentions being found in that time period. This was an increase of over 1,000 posts from the previous month by more than 300 additional authors. Within this conversation the most frequent poster was ‘Head of Children and Young People’s Transformation Programme’ Sara Nelson, who incredibly managed to post 649 posts this month; over 20 posts a day.

This month UK HCPs were most active on 04 October, posting about respiratory diseases 325 times. This aligned with the #askaboutasthma annual campaign which “highlights the simple changes to children and young people’s care that will make a big difference to how they experience their asthma”. Over 200 posts on this day alone included the hashtag with different focuses including inhaler technique, adherence and education and the ‘four asks’. Elsewhere within the online asthma conversation a useful video from GP Amir Khan explained the mechanisms of asthma which received widespread attention.

Throughout September and October many UK HCPs shared the personal struggles they had been experiencing within the NHS recently. Problems including  “inhuman” wait times for patients trying to be admitted to hospitals were cited, as were issues with the retention of the NHS patient-facing workforce, particularly nurses, who were burning out and leaving the healthcare system. This was a particular worry for HCPs who were looking ahead to the winter months and the oncoming wave of respiratory disease patients

In last month’s Respiratory tracker the relationship between the living crisis and health crisis was shown within the context of respiratory disease and this month a similar theme has also emerged. Towards the end of September shocking findings from Asthma + lung UK showed that 15% of responders to their survey had reduced inhaler use to make them last longer in response to the cost of living crisis. This has unfortunately led to more than one million people in the UK experiencing life-threatening asthma attacks, an increase in the demand for Asthma + lung uk services as well as the impact the cost of living crisis has had on the mental health and wellbeing for people with long-term lung conditions. 

Each month, we track the HCP conversation relating to respiratory disease.

You can keep up to date with this and other pharmaceutical tracking updates, including COVID-19 developments, within the Tracking section of CREATION Knowledge, or sign up to receive our monthly eJournal with all of our latest HCP insights. 

If you would like to dig deeper into what we have seen this month then please do get in touch.


  • This article analysed the Twitter conversations of HCPs in the UK discussing respiratory disease and related terms between 21 September and 20 October 2022 using CREATION Pinpoint®.
  • Between 21 September and 20 October 2022, there were 3,682 UK HCP mentions of respiratory disease and related terms, from 1,452 unique UK HCP authors. 

View the latest Respiratory Tracker here

View all articles >

Meet the Author

Mark Sullivan

Mark uses his passion for data analysis to study the online conversations of HCPs and find actionable insights which are presented to teams in the pharmaceutical industry so they can make informed decisions.

Mark is an avid sports fan whether watching or playing. He enjoys spending time with his family and friends and watching films.

Suggested next

Respiratory tracker banner

21.04.2021 | Article

UK HCPs celebrate positive trial for asthma drug used in COVID-19 patients

The key driver behind the spike seen on 12th April was the release of results from the...

By Mark Sullivan

24.08.2021 | Article

UK HCPs Debate The Comparisons Drawn Between COVID-19 And Other Viruses

UK HCPs Debate The Comparisons Drawn Between COVID-19 And Other Viruses

By Mark Sullivan

View all articles >